PhaseBio Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has PhaseBio Pharmaceuticals's balance sheet done over the years? Its assets were worth $60,540,000 last year, which is more than in the previous period. 254% of PhaseBio Pharmaceuticalsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $153,574,000, which means an increase by 103% compared compared to last year.

Debt to Assets

PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS): Debt to assets
2016 4117000 91.29M 2217.61%
2017 14099000 111.51M 790.94%
2018 63026000 12.09M 19.2%
2019 82494000 22.51M 27.29%
2020 50357000 75.55M 150.05%
2021 60540000 153.57M 253.67%

PHAS Balance Sheet (2016 โ€“ 2021)

2021 2020 2019 2018 2017 2016
Assets
Current assets:
Cash and cash equivalents
41.8M28.12M74.02M61.03M13.40M3.71M
Short term investments
000000
Net receivables
001.23M233K00
Inventory
000000
Other current assets
6.98M12.02M3.56M1.36M340K169K
Total current assets
48.78M40.14M78.82M62.62M13.74M3.88M
Non-current assets:
Property, Plant and Equipment
11.69M10.15M3.63M355K302K182K
Goodwill
000000
Intangible assets
000000
Long term investments
000000
Other non-current assets
57K57K32K43K51K51K
Total non-current assets
11.75M10.20M3.67M398K353K233K
Total assets
60.54M50.35M82.49M63.02M14.09M4.11M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1.54M00000
Short term debt
5.41M5.35M2.37M000
Total current liabilities
27.88M14.96M8.47M4.57M17.59M844K
Non-current liabilities:
Long term debt
2.43M6.77M12.32M7.5M2.62M0
Deferred tax
000000
Other non-current liabilities
115.63M53.82M1.71M22K91.29M90.45M
Total non-current liabilities
125.69M60.59M14.03M7.52M93.92M90.45M
Total liabilities
153.57M75.55M22.51M12.09M111.51M91.29M
Data sourceData sourceData sourceData source